Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (6): 992-996    DOI: 10.12892/ejgo4239.2018
Original Research Previous articles | Next articles
Increased expression of lncRNA HULC in human epithelial ovarian cancer and its biological functions
Chen Mi1, Cancan Zhang2, Qi Zhang1, Aiyun Xing1, *()
1 Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China
2 Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, China
Download:  PDF(292KB)  ( 64 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: Long noncoding RNA (lncRNAs) highly upregulated in liver cancer (HULC) has recently been revealed to be upregulated in several human malignancies and correlated with tumor progression. The purpose of this study was to explore the role and function of HULC in human epithelial ovarian cancer (EOC). Materials and Methods: LncRNA HULC expression in EOC tissues and cell lines was detected by quantitative real-time PCR. Then, the association between HULC expression and clinicopathological characteristics and patient survival was analyzed. Furthermore, the effects of HULC on the biological behavior of EOC cells were evaluated by in vitro assays. Results: HULC was significantly upregulated in EOC tissues and cell lines. High level of HULC was associated with advanced FIGO Stage, higher serum CA125 expression level, lymph node metastasis, and poor overall survival. Knockdown of HULC in OVCAR3 was able to reduce cell proliferation, promote cell apoptosis, and inhibit cell invasion. Conclusions: These findings indicate that HULC may exert oncogenic activity in EOC and would serve as a novel prognostic biomarker and therapeutic target for EOC.
Key words:  LncRNA HULC      Epithelial ovarian cancer      Prognosis      Proliferation      Invasion     
Published:  10 December 2018     
*Corresponding Author(s):  AIYUN XING     E-mail:  xingaiyun@mail.com

Cite this article: 

Chen Mi, Cancan Zhang, Qi Zhang, Aiyun Xing. Increased expression of lncRNA HULC in human epithelial ovarian cancer and its biological functions. European Journal of Gynaecological Oncology, 2018, 39(6): 992-996.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4239.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I6/992

[1] Xiao-Peng Yu, Cai-Gang Liu, Fang Qiu, Fei Xing, Si-Jia Han, Ye Han, Gui-Jin He. Breast cancer overall-survival can be predicted with a 19 lncRNA tissue signature[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 838-843.
[2] Burak Tatar. Risk of nodal metastasis associated with lymphovascular space invasion in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 850-854.
[3] Yuanmei Xiao, Aijun Li. Granzyme B expression correlates with poor prognosis in ovarian serous cystadenocarcinoma[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 871-880.
[4] Diane E. Mahoney, Shariska Petersen, Lori Spoozak, Brenda M. Linares, Janet D. Pierce. The role of microbiota in epithelial ovarian cancer: a scoping review[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1006-1017.
[5] Wonkyo Shin, Sang-Yoon Park, Sokbom Kang, Dong Ock Lee, Myong Cheol Lim, Sang-Soo Seo. Effect of positive peritoneal cytology on the prognosis of patients with FIGO stage I endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 730-736.
[6] Ana Carolinne da Silva, Millena Prata Jammal, Renata Margarida Etchebehere, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Association of cancer-associated fibroblasts and survival in malignant ovarian neoplasms[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 782-787.
[7] Anita Agrawal, Mariia Karizhenskaia, Joshua Gitlin, Richa Chibbar, Cheng-Han Lee, Rajni Chibbar. An unusual mullerian carcinoma with myoepithelial differentiation (adenoid cystic carcinoma-like) of the ovary: case report[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 811-816.
[8] Mehmet Sait Bakır, Özer Birge, Ceyda Karadag, Selen Doğan, Hasan Aykut Tuncer, Tayup Simsek. Clinicopathological risk factors and survival analysis of ovarian cancer with synchronous endometrial cancer diagnosed after surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 499-505.
[9] Meng-Hui Huang, Yun Han, Qing-Hua Xi, Yun-Feng Jin, Ying-Lei Liu, Yu-Wen Han, Hai-Li Kai, Qian Zhang, Yan-Li Zheng. Exploration on correlation of high DLX2 expression with poor prognosis and cellular proliferation in epithelial ovarian cancers[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 521-529.
[10] Yu Fu, Rui-Rui Jin, Yi-Lin Li, Hua Luan, Tao Huang, Yuan Zhao, Lin Yang, Fa-Hui Niu, Qing-Mei Sun, Qing Liu, Yong-Xiu Yang. Isocorydine inhibits the proliferation of human endometrial carcinoma HEC-1B cells by downregulating the Ras/MEK/ERK signaling pathway[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 548-553.
[11] Wen-Xue Li, Rui-Qi Zhou, Yao Liu, Gui-Yu Zhang. Expression and clinical relevance of cell division cycle associated 8 (CDCA8) gene in endometrial cancer patients[J]. European Journal of Gynaecological Oncology, 2021, 42(2): 278-285.
[12] Chun-Yu Zhang, Chun-Yan Chen, Hai-Xia Wen, Zi-Feng Song, Ping-Ping Hu. miR-182-5p enhances cisplatin resistance in epithelial ovarian cancer by downregulating GRB2[J]. European Journal of Gynaecological Oncology, 2021, 42(2): 353-359.
[13] Ece Gumusoglu, Tuba Gunel, Mohammad Kazem Hosseini, Nogayhan Seymen, Taylan Senol, Uğur Sezerman, Samet Topuz, Kılıç Aydınlı. The importance of dysregulated miRNAs on ovarian cysts and epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 66-72.
[14] Burak Tatar. Assessment of myometrial invasion of endometrial carcinoma with preoperative transvaginal sonography[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 85-89.
[15] Sefa Kurt, Selim Kandemir, Onur Yavuz, Meral Koyuncuoglu, Emine Cagnur Ulukus, Murat Celiloglu. Persistent tubal epithelium in ovaries after salpingectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 919-923.
No Suggested Reading articles found!